| Objective: With the aging of age and the increase of social pressure,stroke has become a major risk factor for disability and death in the world.Cerebral hemorrhage is the most serious group and morbidity and mortality of this are a major proportion of stroke.Hypertensive cerebral hemorrhage(HICH)refers to long-term hypertension and cerebral arteriosclerosis caused by hypertension,due to blood pressure fluctuations,cerebrovascular rupture and bleeding are common in neurology,resulting in serious complications and even death of patients.The traditional craniotomy is often used to treat this disease,in recent years,with the development of minimally invasive puncture drainage,which bring a new treatment for HICH,because of its simple operation,less trauma,short operation time,low cost advantages,it has been gradually accepted by doctors and patients and used in clinical treatment of this kind of disease.However,so far,it is necessary for this operation to further investigate the safe and effective in the treatment of HICH,therefore,in this study,patients with hypertensive cerebral hemorrhage were retrospectively enrolled to investigate the effect and safe of minimally invasive puncture drainage in the treatment of this disease,so as to provide more in the on the basis of reference and clinical treatment of HICH.Methods: From September 2016 to August 2017,108 patients with HICH(Hypertensive intra cerebral hemorrhage)were included in the study as subjects,all patients were diagnosed by head CT scan,and the clinical manifestation of the patients coincide with the standard of the fourth cerebral vascular Academic Conference on hypertensive intracerebral hemorrhage.According to the treatment methods,these enrolled patients were divided into two groups,one for the study group and another for the control group.The patients from control group were treated with craniotomy,and the patients from study group were treated with microinvasive hematoma puncture drainage.The total efficacy,neurological defect score,intraoperative blood loss,operative time,complication rate and long-term efficacy were analyzed in two groups.Results:(1)There was no statistic difference in the age,gender,blood loss,hemorrhage,bleeding,incidence and GCS score between the control and study group(P>0.05).(2)Compared with the control group,the total effective rate of the patients in the study group was increased(95.75% vs 78.72%,P < 0.05).(3)There was no statistic difference in neurological deficit score between the control and study group before treatment(25.95 + 4.58 vs 25.81 + 4.46,P > 0.05),compared with before treatment,the neurological deficit score was decreased after treatment in two groups(25.95 + 4.58 vs 16.98 + 4.73,25.81 + 4.46 vs 10.17 + 3.29,P<0.05),compared with control group,neurological deficit score was also decreased in study group(16.98 + 4.73 vs 10.17 + 3.29,P<0.05).(4)Compared with the control group,the amount of bleeding was reduced in the study group(298.61 + 40.85 ml vs 89.76 + 19.93 ml,P < 0.05).(5)Compared with the control group,the operation time was shortened in the study group(98.37 + 9.51 min vs 44.28 + 5.75 min,P < 0.05).(6)Compared with the control group,the incidence rate of complications was lower in study group after the treatment(23.40% vs 4.26%,P < 0.05).(7)The patients were given follow-up,the follow-up time was 6 months,compared with the control group,the recovery rate was increased in study group after the treatment(59.57% vs 85.10%,P < 0.05).Conclusion: The effect of minimally invasive hematoma puncture drainage applied to the treatment of hypertensive cerebral hemorrhage curative is superior to surgical craniotomy,which can effectively improve nerve function defect in patients with hypertension cerebral hemorrhage,to promote the fast recovery of nervous functions,but also reduce the intraoperative blood loss,shorten the operation time,and decrease incidence of postoperative complications,is worthy of promotion of use. |
PDF Full Text Request